GNOM News and Press, Global X Genomics & Biotechnology ETF From 05/17/23

2023-05-17 00:00:00 ET Summary Markets are being shaped by disparate trends from falling energy prices to rising interest rates. During first-quarter earnings season, company reports indicated that these crosscurrents are intensifying business challenges—and making it harde...

2023-05-16 14:35:00 ET Summary Both the Consumer Price Index and Producer Price Index data for April confirmed that the strong but lumpy disinflationary trend continues. The US is now at a point where the Fed funds rate exceeds inflation. Historically that has signaled the end of ...

2023-05-15 13:44:44 ET Shares of the SPDR S&P Biotech ETF ( NYSEARCA: XBI ) moved up to a new 3-month trading high on Monday afternoon as the exchange traded fund picked up 3.5% on the day. Moreover, the fund opened trading at $85.72 a share and moved up to $88.20 a...

2023-05-02 01:25:00 ET Summary Interest rates continue to drive markets, with central banks walking a fine line between taming inflation and avoiding recession. The Fed isn’t quite finished with the tightening cycle yet, even as the market remains optimistic that rates will...

2023-04-17 10:30:00 ET Summary The joint stock-bond rally this year has put renewed focus on portfolio construction approaches. We think a new macro regime needs a new approach. U.S. stocks rose last week but lost steam on Friday on the market partly pricing out potential rate cut...

2023-03-25 09:17:25 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips CRISPR could revolutionize the way we treat thousands of diseases. Currently, there are about 7,000 caused by genetic disorders, which occur when a mutation affects your genes, or when you ha...

2023-03-24 03:00:00 ET Summary We remain selective in taking risk as macro factors continue to drive sentiment. Despite the uncertainties, investors should not lose sight of equities’ enduring role in a well-balanced portfolio. We advocate a near-term focus on resilienc...

2023-03-23 08:56:52 ET Popular biotech exchange traded fund SPDR S&P Biotech ETF ( NYSEARCA: XBI ) dropped more than 3% on Wednesday. As a result, the ETF reached a new 8-month low. XBI touched $73.06 a share on Wednesday which marked its lowest level dating back to ...

2023-03-22 08:54:00 ET Summary Technology and healthcare are good examples of sectors that can play different equity-allocation roles than you might expect. Unlike income-oriented defensive sectors, which are sensitive to changes in interest rates, some of the highest-quality low-...

2023-03-16 15:51:00 ET Summary How SVB's collapse is impacting healthcare startups. Pfizer to buy Seagen for $43B. What it means for the sector. Why healthcare startups could face funding challenges. The collapse of Silicon Valley Bank is raising concerns about fun...